BioSpace News Archive

Science 37 Holdings, Inc. and Syapse®, today announced a partnership to deploy proprietary real-world data intelligence and analytics that will help identify suitable patients for oncology clinical trials—ultimately speeding up the enrollment process.

AUM Biosciences announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to AUM601, a highly selective, oral small molecule that inhibits not only pan-TRK (TRKA, TRKB, and TRKC), but also resistance mutations of TRKs, by blocking the activity of tyrosine kinases.

Pasithea Therapeutics Corp. today announced it will present the preclinical proof of concept study results of its tolerizing vaccine program in multiple sclerosis (“MS”) on August 30th at the international conference “From Laboratory to Clinic: Medicine after COVID” held at Trinity College, Oxford University, United Kingdom.

Aligned Orthopedic Partners today announced a partnership with the Jordan-Young Institute, a specialized orthopedic practice with renowned physicians at the cutting edge of orthopedics, neurosurgery and physiatry.

Invicro LLC (Invicro), a global, industry-leading imaging CRO, and a subsidiary of REALM IDx, Inc., today announced the publication of the paper “Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease 1” in Science Translational Medicine.

Publication in Nature Molecular Psychiatry Supports Genuv’s Alternate Theory for Treatment of Alzheimer’s Disease.

Woebot Health today announced that it has appointed Robbert Zusterzeel, M.D., Ph.D., M.P.H., as Vice President of Regulatory Science and Strategy.

Milestone Scientific Inc. reported that, following a successful evaluation, it has commenced sales of its CompuFlo® Epidural disposables to UofL Health, a leading academic health system based in Louisville, Kentucky.

Standigm Inc. (“Standigm”), the leading workflow artificial intelligence (AI) drug discovery company, today announced the appointment of Chief Business Officer Carl Foster.

NuvoAir, a digital health company focused on complex patients, initially targeting respiratory conditions, has shared results of its U.S. chronic obstructive pulmonary disease (COPD) pilot.